RJFSA
CCXI

Raymond James Financial Services Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-85,738
Closed -$4.43M – 3437
2022
Q3 		$4.43M Sell
85,738
-173,781
-67% -$7.18M 0.01% 978
2022
Q2 		$6.43M Buy
259,519
+12,347
+5% +$272K 0.01% 816
2022
Q1 		$6.2M Sell
247,172
-11,925
-5% -$335K 0.01% 898
2021
Q4 		$9.43M Sell
259,097
-122,763
-32% -$4.31M 0.02% 711
2021
Q3 		$6.53M Buy
381,860
+65,158
+21% +$1.02M 0.01% 834
2021
Q2 		$4.24M Buy
316,702
+81,903
+35% +$2.02M 0.01% 1057
2021
Q1 		$12M Buy
234,799
+34,694
+17% +$2.09M 0.03% 552
2020
Q4 		$12.4M Buy
200,105
+142,812
+249% +$8.18M 0.03% 484
2020
Q3 		$3.14M Sell
57,293
-5,387
-9% -$290K 0.01% 963
2020
Q2 		$3.61M Buy
62,680
+24,232
+63% +$1.32M 0.01% 836
2020
Q1 		$1.54M Buy
38,448
+31,498
+453% +$1.34M 0.01% 1011
2019
Q4 		$275K Buy
+6,950
New +$122K ﹤0.01% 2372

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raymond James Financial Services Advisors's CCXI Position: Q4 2022 in Review

Raymond James Financial Services Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 85,738 shares — an estimated $4.43M sold.

Raymond James Financial Services Advisors first reported a position in CCXI in Q4 2019 and held it in 12 quarters. The position peaked at $12.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Raymond James Financial Services Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 85,738 ChemoCentryx, Inc. shares in Q4 2022, an estimated $4.43M.
  • Raymond James Financial Services Advisors first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 12 quarters.
  • Raymond James Financial Services Advisors's ChemoCentryx, Inc. position peaked at $12.4M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.